Comparison of hospitalization costs for the same adverse reaction associated with different medications.

Author: AlabbasSama A, AspinallSherrie L, AuAnthony, BounthavongMark, CunninghamFrancesca E, GlassmanPeter A, GoodChester B, JiangRong, MooreVon R, SaloneCedric, StroupeKevin, VuMichelle

Paper Details 
Original Abstract of the Article :
Costs of hospitalization due to severe adverse drug reactions (ADRs) were previously estimated within the Veterans Health Administration (VHA), but additional analyses are needed to infer potential interventions to mitigate these negative outcomes. The objective of this study was to compare specific...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1093/ajhp/zxad060

データ提供:米国国立医学図書館(NLM)

The Cost of Adverse Drug Reactions: Comparing Hospitalization Costs Across Medications

Adverse drug reactions (ADRs) are a significant public health concern, often leading to hospitalization and substantial healthcare costs. This study investigates the hospitalization costs associated with specific ADRs, comparing the costs across different medications with similar indications. The researchers analyzed data from the Veterans Health Administration (VHA), finding substantial variations in hospitalization costs for the same ADRs associated with different medications. The study highlights the importance of considering the cost-effectiveness of different medications in preventing ADRs and minimizing associated healthcare costs.

A Desert of Unexpected Costs: Exploring the Financial Burden of Adverse Drug Reactions

This research takes us into the financial desert associated with adverse drug reactions (ADRs), highlighting the significant costs incurred by individuals and healthcare systems. The study's findings reveal substantial variations in hospitalization costs for the same ADRs associated with different medications, underscoring the importance of considering cost-effectiveness when prescribing medications and exploring strategies to minimize the financial burden of ADRs.

Navigating the Costs of Medications: Making Informed Choices for Patient Care

This study reminds us that the journey of medication use is not always straightforward, and it often comes with unexpected costs. The study's findings highlight the importance of considering the cost-effectiveness of different medications and exploring strategies to prevent ADRs and minimize their financial impact. It's crucial for healthcare providers to weigh the benefits and costs of different medications, prioritizing both patient safety and economic sustainability.

Dr.Camel's Conclusion

This research is like a financial map of the desert of adverse drug reactions, guiding us to understand the potential costs associated with different medication choices. It reminds us that while medications can be essential for treating illness, they can also come with unintended consequences that require careful consideration and management. This research is a reminder that in the desert of healthcare, we must always strive for both effectiveness and sustainability.

Date :
  1. Date Completed 2023-06-08
  2. Date Revised 2023-06-13
Further Info :

Pubmed ID

36994836

DOI: Digital Object Identifier

10.1093/ajhp/zxad060

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.